Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Associations of Serum Iron Status with MAFLD and Liver Fibrosis in the USA: a Nationwide Cross-Section Study
Genfeng Yu, Lan Liu, Tao Qin, et al.
Biological Trace Element Research (2023) Vol. 202, Iss. 1, pp. 87-98
Closed Access | Times Cited: 11

Showing 11 citing articles:

Associations of thyroid feedback quantile-based index with diabetes in euthyroid adults in the United States and China
Heng Wan, Genfeng Yu, Yajun He, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 8
Association of sensitivity to thyroid hormones with all-cause mortality in euthyroid US adults: a nationwide cohort study
Genfeng Yu, Si‐Yang Maggie Liu, Cheng Song, et al.
European Thyroid Journal (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols
Raissa Bulaty Tauil, Paula Takano Golono, Enzo Pereira de Lima, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1354-1354
Open Access | Times Cited: 6
Iron overload is closely associated with metabolic dysfunction‐associated fatty liver disease in type 2 diabetes
Huanjia Qu, Lingling Zhou, Jing Wang, et al.
Obesity (2025)
Open Access
Multifaceted environmental factors linked to metabolic dysfunction-associated fatty liver disease: an environment-wide association study
Rui Dong, Ting Tian, Ming Chen, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Exploring the Role of Metabolic Hyperferritinaemia (MHF) in Steatotic Liver Disease (SLD) and Hepatocellular Carcinoma (HCC)
Nikolaos-Andreas Anastasopoulos, Alexandra Barbouti, Anna Goussia, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 842-842
Open Access
Association of serum iron status with MASLD and liver fibrosis
Wenying Guo, Ting Weng, Yufei Song
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0319057-e0319057
Open Access
Editorial: Evaluating the Prevalence of Metabolic Dysfunction‐Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinemia
Nakul J. Bhardwaj, Rebecca G. Kim
Alimentary Pharmacology & Therapeutics (2024)
Closed Access | Times Cited: 1
Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
Eleftheria Makri, Myrsini Orfanidou, Evangelia Makri, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 14, Iss. 3, pp. 101353-101353
Closed Access
Serum iron status is associated with all-cause mortality in metabolic dysfunction-associated steatotic liver disease: a prospective, observational study
Ting Xia, Jie Ni, Yifei Ni, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Hepatoprotective effects of an iron chelator, deferoxamine, in a mouse model of metabolic dysfunction-associated fatty liver disease
Jeong Yoon Choi, Jayong Chung
Journal of Nutrition and Health (2024) Vol. 57, Iss. 6, pp. 580-580
Open Access
Page 1

Scroll to top